Savara
(NASDAQ) SVRA
Savara Financials at a Glance
Market Cap
$1.08B
Revenue (TTM)
$0.00
Net Income (TTM)
-$129.48M
EPS (TTM)
-$0.56
P/E Ratio
-9.40
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$5.31
Volume
1,026,853.408
Open
$5.30
Price
$5.31
Volume
1,026,853.408
Open
$5.30
Previous Close
$5.30
Daily Range
$5.24 - $5.43
52-Week Range
$1.98 - $7.01
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.85 (Low)
Price
$5.31
Volume
1,026,853.408
Open
$5.30
Previous Close
$5.30
Daily Range
$5.24 - $5.43
52-Week Range
$1.98 - $7.01
Estimated Earnings Date
Aug 6, 2026
SVRA News
SVRA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Savara
Industry
Biotechnology
Sector
Health CareEmployees
70
CEO
Matthew Pauls, MBA
Website
www.savarapharma.comHeadquarters
Langhorne, TX 78746, US
SVRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-80%
Return on Capital
-65%
Return on Assets
-58%
Earnings Yield
-10.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.08B
Shares Outstanding
204.93M
Volume
1.03M
Avg. Volume
1.52M
Financials (TTM)
Gross Profit
-$245.00K
Operating Income
-$123.55M
EBITDA
-$123.46M
Operating Cash Flow
-$101.04M
Capital Expenditure
-$22.00K
Free Cash Flow
-$101.06M
Cash & ST Invst.
$235.70M
Total Debt
$29.91M
Savara Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$66.00K
+92.7%
Gross Margin
0.00%
N/A
Market Cap
$1.08B
N/A
Market Cap/Employee
$18.24M
N/A
Employees
59
N/A
Net Income
-$37.28M
-40.0%
EBITDA
-$38.92M
-40.9%
Quarterly Fundamentals
Net Cash
$172.71M
+20.9%
Accounts Receivable
$1.05M
+0.7%
Inventory
$0.00
N/A
Long Term Debt
$30.07M
+1.8%
Short Term Debt
$0.00
-100.0%
Return on Assets
-58.42%
N/A
Return on Invested Capital
-65.07%
N/A
Free Cash Flow
-$33.10M
-21.7%
Operating Cash Flow
-$33.05M
-21.5%